Antibe Therapeutics Provides Update on Phase 2B Dose-Ranging, Efficacy Study for ATB-346
TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain…
Pharmaceuticals, Biotechnology and Life Sciences
TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain…
COPENHAGEN, Denmark–(BUSINESS WIRE)–Cirqle Biomedical today announced that it has secured $1.8M for pre-clinical development of a novel non-hormonal contraceptive technology.…
HONG KONG–(BUSINESS WIRE)–Great Bay Bio, a leading AI biotechnology company dedicated to big data-driven CMC (Chemistry Manufacturing and Controls) development…
– Based on the successfully completed single-dose part of the phase I clinical trial in Korean population carried out by…
–(BUSINESS WIRE)–ReAlta Life Sciences, Inc. is an early stage pharmaceutical company incorporated in late 2018, and located in Norfolk, Virginia.…
NEW YORK–(BUSINESS WIRE)–AMNICELL, a biotech company focusing on research and development of amniotic fluid stem cells, today announced that Helen…
NORFOLK, Va.–(BUSINESS WIRE)–Ulrich Thienel MD, PhD, has been appointed by the ReAlta Life Sciences Board of Directors as Chief Executive…
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–PharPoint Research Inc., a contract research organization (CRO) focused on bringing pharmaceutical and biotechnological products to…
— Currie will lead engagement with policymakers, regulators, and advocacy organizations as company advances breakthrough technology for early cancer detection…
LONDON–(BUSINESS WIRE)–#Analytics–A global data analytics and advisory firm, Quantzig, has announced the completion of their latest clinical trial data analysis…